ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,287,000 | +37.1% | 19,100 | 0.0% | 2.57% | +77.9% |
| Q2 2021 | $2,397,000 | -7.5% | 19,100 | 0.0% | 1.44% | +10.6% |
| Q1 2021 | $2,590,000 | +6.0% | 19,100 | 0.0% | 1.31% | +1.6% |
| Q4 2020 | $2,444,000 | +13.7% | 19,100 | 0.0% | 1.29% | +112.6% |
| Q3 2020 | $2,149,000 | +182.0% | 19,100 | +138.8% | 0.60% | +152.1% |
| Q2 2020 | $762,000 | +6.0% | 8,000 | 0.0% | 0.24% | +20.6% |
| Q1 2020 | $719,000 | +69.6% | 8,000 | 0.0% | 0.20% | +158.4% |
| Q4 2019 | $424,000 | -89.5% | 8,000 | -95.1% | 0.08% | -99.8% |
| Q3 2015 | $4,036,000 | -21.3% | 162,070 | 0.0% | 43.03% | +27.1% |
| Q2 2015 | $5,128,000 | +43.7% | 162,070 | +72.8% | 33.85% | +106.2% |
| Q1 2015 | $3,569,000 | +64.2% | 93,781 | +68.2% | 16.42% | +413.1% |
| Q4 2014 | $2,173,000 | +28.9% | 55,767 | 0.0% | 3.20% | +98.1% |
| Q3 2014 | $1,686,000 | -11.0% | 55,767 | 0.0% | 1.62% | +1.7% |
| Q2 2014 | $1,894,000 | +162.7% | 55,767 | +166.9% | 1.59% | +213.8% |
| Q1 2014 | $721,000 | -72.4% | 20,892 | -68.3% | 0.51% | -80.1% |
| Q4 2013 | $2,614,000 | – | 66,000 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |